| PUBCHEM ID |
77843968
|
| UNII |
E39B3691TD
|
| Preferred Term |
VL-2397
|
| CAS |
1186200-57-6
|
| INCHIKEY |
NRHTWBFQTMOOKS-FELWXBABSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC(C)C[C@H](C(N[C@@H](Cc1ccccc1)C(N[C@H](CCCN(C(C)=O)O)C(N[C@H](CCCN(C(C)=O)O)C(N[C@H](CCCN(C(C)=O)O)C(N[C@@H]1CC(N)=O)=O)=O)=O)=O)=O)NC1=O
|
| Total Surface Area |
678,41
|
| Relative PSA |
0,38971
|
| TPSA |
339,31
|
| cLogS |
-3,311
|
| MW |
890,989
|
| cLogP |
-3,3085
|
| H-Acceptors |
23
|
| H-Donors |
10
|
| Ro5 violations |
3
|
| Druglikeness |
4,4023
|
| DrugScore |
0,166442546013284
|
| Mutagenic |
high
|
| Tumorigenic |
high
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA-
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,394
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,7364
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,4035
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,5876
|
| Carcinogenicity (Three-class) |
Non-required
|
